NHF’s premier research fellowship program is named in honor of Dr. Judith Graham Pool. Established by NHF in 1972, the Judith Graham Pool (JGP) Postdoctoral Research Fellowships have provided a long legacy of support for basic science and pre-clinical research in bleeding disorders. In 1965, Dr. Pool discovered a method of extracting clotting factor from human plasma to formulate cryoprecipitate. This breakthrough opened the door to a series of research developments that would revolutionize treatment for hemophilia and ultimately lead to its management through recombinant replacement factor and current extended half-life therapies.
There is an urgent need to better understand the pathobiology and both long term and immediate clinical implications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral infection that leads to the morbidity and mortality seen with COVID-19, as well as increase knowledge about the potential emerging threat of other novel respiratory viruses. The American Lung Association is looking for proposals to advance research against emerging respiratory pathogens like SARS-CoV-2. All research must directly be related to COVID-19 or other viral respiratory threats that may arise in the future.
Bristol Myers Squibb Foundation and National Medical Fellowships—Diversity in Clinical Trials Career Development Program (DCTCDP)
In partnership, the Bristol Myers Squibb Foundation and National Medical Fellowships have created the Diversity in Clinical Trials Career Development Program (DCTCDP) aimed at increasing diversity in clinical trials.
Sanofi US is committed to funding high quality educational activities and materials in the therapeutic areas of interest to the company that have the potential to improve patient care and health outcomes. The purpose of an educational grant is to support an activity that encourages an educational interchange with respect to available scientific and medical information. Educational activities may or may not be accredited.
Gilead welcomes funding requests for innovative, high-impact projects that relate to at least one of five core therapeutic areas:
In addition to sponsoring its own research and research collaborations, Lilly has programs for considering external requests for Lilly provision of study drug and/or financial support for Investiga
Grants for IME for the following disease states: Disease States: Acute Myeloid Leukemia, Age-related Macular Degeneration, ALK-Positive Non-small cell lung cancer, basal cell carcinoma, bladder can
Boston Scientific provides support for research that advances medical and scientific knowledge about our products and that generates medical interventions.
Pioneering Ideas: Exploring the Future to Build a Culture of Health seeks proposals that are primed to influence health equity in the future. RWJF is interested in ideas that address any of these four areas of focus: Future of Evidence; Future of Social Interaction; Future of Food; Future of Work. Additionally, RWJF welcomes ideas that might fall outside of these four focus areas, but which offer unique approaches to advancing health equity and our progress toward a Culture of Health.